SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF Portfolio
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (373)1/7/1999 9:57:00 AM
From: Henry Niman  Read Replies (1) of 1073
 
Actually, I began working on hybridomas in 1978 at Scripps, right after taking my Ph.D. degree from USC. The technology worked quite well very early, with publications beginning in 1980. Maybe it was those balb/c mice at USC that slowed things down up there :-).

In any event, has this thread made enough noise to get buyers interested in 3rd tier Biotechs? Just this week the WSJ had a fairly extensive article on Biotech investing for the past decade and the article (linked to the Biotech Boom table at biocognizance.com) made it sound like there was still a lack of listeners for those falling trees. The above page also has links to a fairly recent report by Jean Deleage, who has been funding Biotechs since GNE, and he also warned of a big time consolidation, with many casualties. Sounds like this thread still has some work to do.

Any comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News